These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 15986976)

  • 1. A retroperitoneal bleed induced by enoxaparin therapy.
    Ernits M; Mohan PS; Fares LG; Hardy H
    Am Surg; 2005 May; 71(5):430-3. PubMed ID: 15986976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases.
    Dabney A; Bastani B
    Intensive Care Med; 2001 Dec; 27(12):1954-7. PubMed ID: 11797033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
    Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
    Hammerstingl C; Omran H; Tripp C; Poetzsch B
    Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of enoxaparin- and/or warfarin-induced massive retroperitoneal bleeding: report of a case and review of the literature.
    Topgül K; Uzun O; Anadol AZ; Gök A
    South Med J; 2005 Jan; 98(1):104-6. PubMed ID: 15678643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early ambulation and variability in anticoagulation during elective coronary stenting with a single intravenous bolus of low-dose, low-molecular weight heparin enoxaparin.
    Zalc S; Lemos PA; Esteves A; Ribeiro EE; Horta P; Nicolau JC; Ramires JA; Cohen M; Martinez EE
    J Invasive Cardiol; 2006 Feb; 18(2):45-8. PubMed ID: 16446514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel.
    Cherfan A; Arabi Y; Al Askar A; Al Shimemeri A
    Pharmacotherapy; 2007 May; 27(5):755-9. PubMed ID: 17461711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin-induced spontaneous massive retroperitoneal hematoma with fatal outcome.
    Salemis NS; Oikonomakis I; Lagoudianakis E; Boubousis G; Tsakalakis C; Sourlas S; Gourgiotis S
    Am J Emerg Med; 2014 Dec; 32(12):1559.e1-3. PubMed ID: 24972961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive retroperitoneal hematoma during enoxaparin treatment of pulmonary embolism after primary total hip arthroplasty: case reports and review of the literature.
    Lee MC; Nickisch F; Limbird RS
    J Arthroplasty; 2006 Dec; 21(8):1209-14. PubMed ID: 17162185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous perirenal hematomas in patients taking anticoagulation medication or having a bleeding diathesis].
    Seseke S; Schreiber M; Rebmann U; Seseke F
    Aktuelle Urol; 2008 May; 39(3):215-8. PubMed ID: 18478495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin-induced retroperitoneal hematoma.
    Melde SL
    Ann Pharmacother; 2003 Jun; 37(6):822-4. PubMed ID: 12773070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW
    Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal failure and low molecular weight heparins. A dangerous liaison? The case of retroperitoneal hematoma.
    Kravitz MS; Mishaal RA; Shoenfeld Y
    Isr Med Assoc J; 2005 Sep; 7(9):600-1. PubMed ID: 16190487
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
    Califf RM; Petersen JL; Hasselblad V; Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S91-9. PubMed ID: 16124953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal hematoma due to spontaneous lumbar artery rupture during fondaparinux treatment. Case report and review of the literature.
    Fortina M; Carta S; Del Vecchio EO; Crainz E; Urgelli S; Ferrata P
    Acta Biomed; 2007; 78(1):46-50. PubMed ID: 17687817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening abdominal wall hematoma in a chronic renal failure patient after a single dose of enoxaparin.
    Weinsheimer RL; Libby E; Howdieshell TR
    Am Surg; 2005 Feb; 71(2):132-4. PubMed ID: 16022012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of low-molecular-weight heparin to bridge therapy in obese patients and in patients with renal dysfunction.
    George-Phillips KL; Bungard TJ
    Pharmacotherapy; 2006 Oct; 26(10):1479-90. PubMed ID: 16999658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.